| M04AB01 |
M04AB01 probenecid |
| M04AB02 |
M04AB02 sulfinpyrazone |
| M04AB03 |
M04AB03 benzbromarone |
| M04AB04 |
M04AB04 isobromindione |
| M04AB05 |
M04AB05 lesinurad |
| M04AC |
M04AC Preparations with no effect on uric acid metabolism |
| M04AC01 |
M04AC01 colchicine |
| M04AC02 |
M04AC02 cinchophen |
| M04AX |
M04AX Other antigout preparations |
| M04AX01 |
M04AX01 urate oxidase |
| M04AX02 |
M04AX02 pegloticase |
| M05 |
M05 Drugs for treatment of bone diseases |
| M05B |
M05B Drugs affecting bone structure and mineralization |
| M05BA |
M05BA Bisphosphonates |
| M05BA01 |
M05BA01 etidronic acid |
| M05BA02 |
M05BA02 clodronic acid |
| M05BA03 |
M05BA03 Pamidronic acid |
| M05BA04 |
M05BA04 Alendronic acid |
| M05BA05 |
M05BA05 Tiludronic acid |
| M05BA06 |
M05BA06 Ibandronic acid |
| M05BA07 |
M05BA07 Risedronic acid |
| M05BA08 |
M05BA08 Zoledronic acid |
| M05BB |
M05BB Bisphosphonates, combinations |
| M05BB01 |
M05BB01 etidronic acid and calcium, sequential |
| M05BB02 |
M05BB02 risedronic acid and calcium, sequential |
| M05BB03 |
M05BB03 alendronic acid and colecalciferol |
| M05BB04 |
M05BB04 risedronic acid, calcium and colecalciferol, sequential |
| M05BB05 |
M05BB05 alendronic acid, calcium and colecalciferol, sequential |
| M05BB06 |
M05BB06 alendronic acid and alfacalcidol, sequential |
| M05BB07 |
M05BB07 risedronic acid and colecalciferol |